| Feb 21, 2019 |
Feb 25, 2019 |
GALECTIN THERAPEUTICS INC
|
Director |
Sell |
7.5
|
-51,185
|
-55.68%
|
✓
|
$308.2K |
| Jan 23, 2019 |
Jan 25, 2019 |
CURIS INC
|
Director |
Sell |
13.8
|
-18,500
|
-39.10%
|
✓
|
$19.5K |
| Sep 21, 2018 |
Sep 25, 2018 |
TITAN PHARMACEUTICALS INC
|
Chair |
Buy |
95.0
|
+400,000
|
255.89%
|
✗
|
$100K |
| Sep 4, 2018 |
Sep 6, 2018 |
GALECTIN THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-11,900
|
-36.64%
|
✓
|
$78.3K |
| Aug 30, 2018 |
Sep 4, 2018 |
GALECTIN THERAPEUTICS INC
|
Director |
Sell |
7.5
|
-58,100
|
-68.69%
|
✓
|
$353.3K |
| Dec 8, 2017 |
Dec 8, 2017 |
GALECTIN THERAPEUTICS INC
|
Director |
Buy |
91.3
|
+7,000
|
14.41%
|
✗
|
$13K |
| Dec 8, 2017 |
Dec 8, 2017 |
GALECTIN THERAPEUTICS INC
|
Director |
Buy |
91.3
|
+7,000
|
14.41%
|
✗
|
$13K |
| Nov 16, 2017 |
Nov 16, 2017 |
CURIS INC
|
Director |
Buy |
91.3
|
+25,000
|
94.00%
|
✗
|
$24.5K |
| Jan 11, 2016 |
Jan 11, 2016 |
TITAN PHARMACEUTICALS INC
|
Chair |
Buy |
83.8
|
+5,000
|
3.30%
|
✗
|
$16.3K |
| Aug 28, 2015 |
Aug 31, 2015 |
TITAN PHARMACEUTICALS INC
|
Chair |
Buy |
86.3
|
+50,000
|
6.39%
|
✗
|
$35.8K |
| Oct 9, 2014 |
Oct 14, 2014 |
TITAN PHARMACEUTICALS INC
|
Chair |
Buy |
91.3
|
+100,000
|
16.47%
|
✗
|
$48.2K |
| Dec 4, 2013 |
Dec 4, 2013 |
GALECTIN THERAPEUTICS INC
|
Director |
Buy |
91.3
|
+3,000
|
89.98%
|
✗
|
$26.1K |
| Jun 17, 2013 |
Jun 19, 2013 |
TITAN PHARMACEUTICALS INC
|
Chair |
Buy |
91.3
|
+50,000
|
12.09%
|
✗
|
$22.7K |
| Nov 18, 2011 |
Nov 21, 2011 |
TITAN PHARMACEUTICALS INC
|
Chair |
Buy |
91.3
|
+38,400
|
10.24%
|
✗
|
$48.9K |
| Oct 18, 2011 |
Oct 20, 2011 |
GALECTIN THERAPEUTICS INC
|
Director |
Buy |
91.3
|
+20,000
|
100.00%
|
✗
|
$19.2K |
| Dec 10, 2010 |
Dec 14, 2010 |
CURIS INC
|
Director |
Buy |
95.0
|
+26,596
|
100.00%
|
✗
|
$50.3K |
| Feb 5, 2008 |
Feb 7, 2008 |
TITAN PHARMACEUTICALS INC
|
President |
Buy |
91.3
|
+30,000
|
30.00%
|
✗
|
$40K |